- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 453
ScaleIO stores $12m
Amnon Bar-Lev, the president of network security software company Check Point Software Technologies joins affiliate fund of Greylock Ventures, Greylock Israel Partners, and Norwest Venture participating in a $12m first round of funding for software design storage company ScaleIO.
Dec 17, 2012Medtronic flexes way into MC10 round
Medtronic is one of two strategic investors backing MC10's technology, which makes it is easier to twist, stretch and expand integrated circuits, which can be used inside or on the human body.
Dec 17, 2012Lundbeckfond, SR One lead River Vision A round
Lundbeckfond Ventures and SR one co-lead a $17m Series A round into US-based River Vision Development Corp, a company managed under contract with Narrow River for developing the drug RV001
Dec 16, 2012Cerapedics grafts for $19m
MedImmune Ventures and CVF co-lead a $19m Series C into US-based medical device company Cerapedics.
Dec 16, 2012Cerulean raises $13m
US-based Cerulean Pharma, a nanopharmaceutical company backed by Lilly Ventures, raises $13m from a consortium of previous backers, bringing the total raised by the drug company to $80m.
Dec 14, 2012HelloFresh cooks up $10m
Vorwerk Ventures participates in a $10m round of funding for UK-based recipe subscription service HelloFresh.
Dec 12, 2012Novartis treats Galera
Novartis, via its Novartis Venture Funds, participates in a $11m Series A round for cancer treatment company Galera Therapeutics.
Dec 12, 2012Epic Sciences receives an injection of $13m
US-based Epic Sciences, a biotech and cancer diagnostics company, raises $13m in Series B financing.
Dec 9, 2012BioMerieux purchases Quanterix stake
US-based Quanterix, a maker of diagnostic tests, closes its Series C round at $18.5m, a round which included a $15m equity stake from multinational biotechnology company BioMerieux.
Dec 6, 2012Morgan Stanley leads Nanostring E round
US-based financial services firm Morgan Stanley has led a $15.3m Series E round for US-based NanoString Technologies, a spin out of Seattle-based Institute for Systems Biology.
Dec 6, 2012About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


